Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cryer

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Current Opinion in Gastroenterology|October 13, 2006
NSAID gastrointestinal toxicityB Cryer
Current Opinion in Gastroenterology|October 13, 2006
Nonsteroidal anti-inflammatory drug gastrointestinal toxicityB Cryer
Gastroenterology Clinics of North America|January 5, 2002
Mucosal defense and repair. Role of prostaglandins in the stomach and duodenumB Cryer
The American Journal of Managed Care|September 26, 2001
The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathyB Cryer
Current Opinion in Gastroenterology|October 7, 2006
Nonsteroidal anti-inflammatory drug gastrointestinal toxicityB Cryer
The American Journal of Cardiology|September 1, 1999
Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solutionM Feldman, B Cryer
Seminars in Gastrointestinal Disease|October 1, 1994
Peptic ulcer disease in the elderlyB Cryer, M Feldman
Proceedings of the Association of American Physicians|November 1, 1996
Racial differences in gastric function among African Americans and Caucasian Americans: secretion, serum gastrin, and histologyB Cryer, M Feldman
Archives of Internal Medicine|June 1, 1992
Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damageB Cryer, M Feldman
Gastroenterology|June 26, 1999
Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humansB Cryer, M Feldman
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Current Opinion in Gastroenterology|October 13, 2006
NSAID gastrointestinal toxicityB Cryer
Current Opinion in Gastroenterology|October 13, 2006
Nonsteroidal anti-inflammatory drug gastrointestinal toxicityB Cryer
Gastroenterology Clinics of North America|January 5, 2002
Mucosal defense and repair. Role of prostaglandins in the stomach and duodenumB Cryer
The American Journal of Managed Care|September 26, 2001
The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathyB Cryer
Current Opinion in Gastroenterology|October 7, 2006
Nonsteroidal anti-inflammatory drug gastrointestinal toxicityB Cryer
The American Journal of Cardiology|September 1, 1999
Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solutionM Feldman, B Cryer
Seminars in Gastrointestinal Disease|October 1, 1994
Peptic ulcer disease in the elderlyB Cryer, M Feldman
Proceedings of the Association of American Physicians|November 1, 1996
Racial differences in gastric function among African Americans and Caucasian Americans: secretion, serum gastrin, and histologyB Cryer, M Feldman
Archives of Internal Medicine|June 1, 1992
Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damageB Cryer, M Feldman
Gastroenterology|June 26, 1999
Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humansB Cryer, M Feldman
Pageof 4